Skip to content

Clinical trials

Terminated Thalassemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thalassemia Status: Terminated Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20042
20101
20121
20141
20151
20161
20172
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baylor College of Medicine3
Bellicum Pharmaceuticals1
Columbia University1
Emory University1
Gamida Cell ltd1
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center1
Masonic Cancer Center, University of Minnesota1
National Institute of Allergy and Infectious Diseases (NIAID)1
Roswell Park Cancer Institute1
Sideris Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thalassemia15
Anemia, Sickle Cell11
Hemoglobinopathies5
Anemia, Diamond-Blackfan3
Granulomatous Disease, Chronic3
Shwachman-Diamond Syndrome3
beta-Thalassemia3
Anemia, Aplastic2
Dyskeratosis Congenita2
Fanconi Anemia2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.